Targeting inflammation and tissue breakdown in osteoarthritis using a new delivery method
Intra-cartilage depot delivery of electrically-charged IL-1RA for targeting osteoarthritis-associated inflammation and catabolism in multiple joint tissues
This study is testing a new way to deliver a treatment directly into the joints of people with osteoarthritis, using special carriers to help the medicine work better and longer, so patients can feel real improvements in their condition instead of just temporary relief.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northeastern University NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10906123 on NIH RePORTER |
What this research studies
This research focuses on improving the treatment of osteoarthritis (OA) by developing a novel method for delivering a therapeutic agent, interleukin-1 receptor antagonist (IL-1RA), directly into joint tissues. The approach utilizes electrically charged carriers to enhance the penetration and retention of the drug within the cartilage, synovium, and subchondral bone, which are critical areas affected by OA. By addressing the limitations of current drug delivery systems, this research aims to stimulate a biological response that modifies the disease process. Patients may benefit from a more effective treatment that targets the underlying causes of OA rather than just alleviating symptoms.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with osteoarthritis, particularly those experiencing inflammation and cartilage degradation.
Not a fit: Patients with osteoarthritis who do not respond to intra-articular treatments or have contraindications for such therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for osteoarthritis, potentially slowing disease progression and improving joint health.
How similar studies have performed: Previous research has shown promise in using electrostatic interactions for drug delivery in cartilage, indicating potential for success with this novel approach.
Where this research is happening
Boston, United States
- Northeastern University — Boston, United States (Active)
Researchers
- Principal investigator: Bajpayee, Ambika Goel — Northeastern University
- Study coordinator: Bajpayee, Ambika Goel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.